These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2873219)

  • 1. The binding of amsacrine to human plasma proteins.
    Paxton JW; Jurlina JL; Foote SE
    J Pharm Pharmacol; 1986 Jun; 38(6):432-8. PubMed ID: 2873219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination kinetics of amsacrine in the rabbit: evidence of nonlinearity.
    Paxton JW; Jurlina JL
    Pharmacology; 1985; 31(1):50-6. PubMed ID: 3839584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.
    Paxton JW; Jurlina JL
    Cancer Chemother Pharmacol; 1986; 16(3):253-6. PubMed ID: 3754493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of amsacrine in patients receiving combined chemotherapy for treatment of acute myelogenous leukemia.
    Jurlina JL; Varcoe AR; Paxton JW
    Cancer Chemother Pharmacol; 1985; 14(1):21-5. PubMed ID: 3855288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4 -acridinecarboxamide in plasma by high-performance liquid chromatography.
    Jurlina JL; Paxton JW
    J Chromatogr; 1985 Aug; 342(2):431-5. PubMed ID: 3840491
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.
    Kestell P; Paxton JW; Evans PC; Young D; Jurlina JL; Robertson IG; Baguley BC
    Cancer Res; 1990 Feb; 50(3):503-8. PubMed ID: 2297692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum.
    Morin D; Simon N; Deprés-Brummer P; Lévi F; Tillement JP; Urien S
    Pharmacology; 1997 May; 54(5):271-5. PubMed ID: 9380773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol binding to human blood proteins.
    Altmayer P; Büch U; Büch HP
    Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.
    Calabrese CR; Loadman PM
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):275-81. PubMed ID: 9106053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs.
    Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 2000; 45(5):417-22. PubMed ID: 10803926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine binding to human plasma proteins.
    Olsen GD
    Clin Pharmacol Ther; 1975 Jan; 17(1):31-5. PubMed ID: 47279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple binding of bepridil in human blood.
    Albengres E; Urien S; Pognat JF; Tillement JP
    Pharmacology; 1984; 28(3):139-49. PubMed ID: 6201931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
    Zini R; Morin D; Jouenne P; Tillement JP
    Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
    Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
    J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.